Earnings
OXFD
21.99
+0.05%
0.01
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2019-12-31
181.27M
--
--
13.67M
--
--
4.66M
--
11.10M
--
5.19M
--
215.88M
14.54M
0.00
--
--
2.48M
87.00K
--
2.26M
19.37M
235.25M
--
2.42M
0.00
--
--
--
--
--
11.28M
--
--
--
124.00K
13.82M
32.00K
--
--
--
7.71M
7.74M
21.56M
276.00K
304.91M
-84.03M
--
--
--
213.69M
213.69M
235.25M
FY 2018-12-31
192.84M
--
--
9.16M
--
--
4.50M
--
7.77M
--
2.51M
0.00
216.78M
7.14M
4.50M
--
--
2.48M
61.00K
--
1.15M
15.34M
232.12M
--
2.80M
0.00
--
--
--
--
--
9.28M
--
--
--
5.85M
18.01M
106.00K
--
--
--
0.00
106.00K
18.11M
276.00K
303.01M
-80.76M
--
--
--
214.01M
214.01M
232.12M
FY 2017-12-31
90.33M
--
--
6.02M
--
--
0.00
--
7.14M
--
2.71M
14.28M
120.48M
2.76M
--
--
--
2.48M
1.04M
--
17.47M
23.75M
144.24M
--
5.55M
0.00
--
--
--
--
--
7.81M
--
--
--
9.01M
22.45M
29.86M
--
--
--
4.31M
34.16M
56.61M
269.00K
294.61M
-201.54M
--
--
--
87.63M
87.63M
144.24M
FY 2016-12-31
59.11M
--
--
13.27M
--
--
0.00
--
7.44M
--
2.39M
--
82.20M
7.79M
--
--
--
3.82M
27.19M
--
3.01M
41.81M
124.01M
--
3.20M
0.00
--
--
--
--
--
14.28M
--
--
--
923.00K
18.49M
29.60M
--
--
--
2.96M
32.56M
51.05M
243.00K
249.13M
-168.66M
--
--
--
72.96M
72.96M
124.01M
FY 2015-12-31
83.72M
--
--
7.06M
--
--
0.00
--
7.10M
--
3.59M
0.00
101.46M
6.28M
--
--
--
45.00K
1.96M
--
98.00K
8.39M
109.85M
--
3.80M
0.00
--
--
--
--
--
9.95M
--
--
--
1.65M
15.48M
386.00K
--
--
--
1.29M
1.68M
17.16M
243.00K
244.03M
-146.31M
--
--
--
92.69M
92.69M
109.85M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out OXFD latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Oxford Immunotec recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.